Loading clinical trials...
Loading clinical trials...
Evaluation of Ultralow Dose PET Imaging for Detecting PSMA Expression
Conditions
Interventions
Piflufolastat F18
Locations
1
United States
Nuclear Imaging Institute
Englewood, New Jersey, United States
Start Date
May 12, 2025
Primary Completion Date
June 30, 2030
Completion Date
June 30, 2030
Last Updated
June 4, 2025
NCT05691465
NCT04550494
NCT06842498
NCT07310264
NCT00090662
NCT05489211
Lead Sponsor
Akiva Mintz
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions